Why Does Feline Infectious Peritonitis (FIP) Cause Ascites

Pathogenesis of FIP and Its Link to Ascites Formation

Feline Infectious Peritonitis (FIP) is a complex, immune-mediated disease caused by certain mutated strains of feline coronavirus (FCoV). Under specific circumstances, this virus transitions from a benign enteric infection to a fatal systemic disorder. The distinct pathological hallmark of the wet form of FIP is the accumulation of straw-colored ascitic fluid within the abdominal cavity. The development of this ascites is primarily driven by immune reactions and vascular alterations triggered by viral infection.

The mutated FCoV infects monocytes and macrophages, leading to widespread dissemination within the host. The immune response is dysregulated, resulting in a granulomatous vasculitis that involves small blood vessels across multiple organs, especially the peritoneum. The inflammation of the peritoneal vasculature increases vascular permeability, allowing plasma components to leak into the peritoneal cavity. This process results in copious accumulation of fluid, manifesting as ascites.

Vascular Inflammation and Increased Permeability

One core contributor to ascites is vasculitis caused by immune complexes and direct viral effects. The infected monocytes and macrophages release inflammatory cytokines such as interleukins and tumor necrosis factor-alpha (TNF-α). These cytokines promote endothelial activation and damage, disrupting the integrity of blood vessel walls. The fragile vasculature becomes more permeable, facilitating the escape of plasma constituents like albumin, electrolytes, and water into the peritoneal space.

This increased permeability is compounded by damage to the endothelial glycocalyx, which acts as a barrier regulating fluid extravasation. The ongoing inflammation perpetuates this cycle, leading to a positive feedback loop that sustains and exacerbates ascitic fluid accumulation.

Alterations in Oncotic and Hyrostatic Pressures

A critical aspect of ascites development in FIP involves the disruption of normal fluid dynamics. The leakage of plasma proteins, notably albumin, into the peritoneal cavity impairs the oncotic pressure gradient that normally retains fluid within the vasculature. As serum albumin levels decline—a condition known as hypoalbuminemia—the plasma's ability to draw fluid back into the blood vessels diminishes.

Simultaneously, local inflammatory swelling increases hydrostatic pressure within subperitoneal blood vessels. Elevated hydrostatic pressure favors fluid movement out of the vasculature into the peritoneal cavity. The imbalance between these forces results in persistent fluid accumulation, characteristic of the wet form of FIP.

Role of Immune Complexes and Hypersensitivity Reactions

The immune-mediated nature of FIP suggests that immune complex deposition plays a substantial role in vascular damage. Circulating immune complexes formed from viral antigens and host antibodies deposit within vessel walls, especially in the peritoneal vasculature, initiating complement activation. This results in vasculitis, further increasing vascular permeability.

Moreover, hypersensitivity reactions in FIP contribute to the severity of vasculitis and subsequent fluid leakage. The cytokine milieu skews toward a Th1 or Th2 response, intensifying inflammation and tissue damage. These immune pathways, while attempting to combat the infection, inadvertently promote the development of ascites.

Peritoneal Mesothelial Cell Activation and Exudate Formation

Beyond vascular insults, the peritoneal lining itself plays a role. FIP-associated cytokines activate mesothelial cells, causing them to produce inflammatory mediators and plasma proteins. This activation enhances the exudation of fluid into the peritoneal cavity, compounded by increased vascular leakage.

Furthermore, the peritoneal mesothelium's response includes hyperplasia and edema, expanding the space available for fluid accumulation. The net effect produces a high-protein, straw-colored exudate, characteristic of FIP-associated ascites.

Lymphatic Drainage Disruption

Normal lymphatic drainage helps maintain fluid homeostasis within the peritoneal cavity. In FIP, inflammation and fibrosis can obstruct lymphatic vessels, impairing the removal of excess fluid. This lymphatic dysfunction further contributes to ascites buildup, making the fluid accumulation more persistent and resistant to resolution.

The protein-rich nature of the exudate also hampers lymphatic function, creating a vicious cycle where reduced clearance exacerbates fluid retention.

Unique Features of FIP-Related Ascites

Unlike transudative ascites caused solely by hypoalbuminemia or increased hydrostatic pressure, FIP-related ascites presents as an exudate rich in proteins, immune cells, and inflammatory mediators. The complex interplay of immune responses, vascular damage, and peritoneal changes distinguishes FIP as a disease with multifactorial mechanisms of ascites formation.

Implications for Treatment and Prognosis

Understanding the underlying mechanisms highlights potential therapeutic targets. Anti-inflammatory agents, immune modulators, and supportive care aimed at restoring vascular integrity and modulating immune responses may help manage ascites. However, given the disease's progression, prognosis remains guarded once extensive ascites develop.

References

1. Pedersen, N. C. (2014). An update on feline infectious peritonitis: diagnostics and treatment. Journal of Feline Medicine and Surgery, 16(4), 1–10.

2. Addie, D. D., & Jarrett, O. (2004). Feline infectious peritonitis. Veterinary Clinics of North America: Small Animal Practice, 34(1), 27–51.

3. Kipar, A., & Meli, M. L. (2014). Feline infectious peritonitis: still an enigma. Veterinary Pathology, 51(2), 505–526.

4. Pedersen, N. C., & Liu, L. (2011). Feline coronavirus infections. The Veterinary Clinics of North America: Small Animal Practice, 41(5), 965–975.

5. Vennema, H., et al. (1998). Feline infectious peritonitis virus infections in cats. Infections of the Gastrointestinal Tract, 263–271.